#mrctoxicologyunit

  1. Cambridge researchers redesign future mRNA therapeutics

    By PharmaTimes One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses Researchers from the University of Cambridge’s Medical Research Council (MRC) Toxicology Unit have redesigned future messenger ribonucleic acid (mRNA) therapeutics to prevent